OncoImmunology
Volume 10, 2021 - Issue 1
Open access
4,726
Views
45
CrossRef citations to date
0
Altmetric
Original Research
YTHDF1 and YTHDF2 are associated with better patient survival and an inflamed tumor-immune microenvironment in non–small-cell lung cancer
Kazuo Tsuchiyaa Department of Tumor Pathology, Hamamatsu University School of Medicine, Hamamatsu, Japan;b Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, JapanView further author information
, Katsuhiro Yoshimuraa Department of Tumor Pathology, Hamamatsu University School of Medicine, Hamamatsu, Japan;b Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, JapanView further author information
, Yusuke Inouea Department of Tumor Pathology, Hamamatsu University School of Medicine, Hamamatsu, Japan;b Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, JapanView further author information
, Yuji Iwashitaa Department of Tumor Pathology, Hamamatsu University School of Medicine, Hamamatsu, JapanView further author information
, Hidetaka Yamadaa Department of Tumor Pathology, Hamamatsu University School of Medicine, Hamamatsu, JapanView further author information
, Akikazu Kawasec First Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, JapanView further author information
, Takuya Watanabed Division of Thoracic Surgery, Respiratory Disease Center, Seirei Mikatahara General Hospital, Hamamatsu, JapanView further author information
, Masayuki Tanahashid Division of Thoracic Surgery, Respiratory Disease Center, Seirei Mikatahara General Hospital, Hamamatsu, JapanView further author information
, Hiroshi Ogawae Department of Pathology, Seirei Mikatahara General Hospital, Hamamatsu, JapanView further author information
, Kazuhito Funaic First Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, JapanView further author information
, Kazuya Shinmuraa Department of Tumor Pathology, Hamamatsu University School of Medicine, Hamamatsu, JapanView further author information
, Takafumi Sudab Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, JapanView further author information
& Haruhiko Sugimuraa Department of Tumor Pathology, Hamamatsu University School of Medicine, Hamamatsu, JapanCorrespondence[email protected]
View further author information
show allView further author information
Article: 1962656
|
Received 16 Apr 2021, Accepted 26 Jul 2021, Published online: 10 Aug 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.